On Monday, PainReform Ltd (NASDAQ: PRFX) opened higher 4.26% from the last sessionbefore settling in for the closing price of $0.87. Price fluctuations for PRFX have ranged from $0.76 to $25.08 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 53.92% at the time writing. With a float of $0.37 million, this company’s outstanding shares have now reached $1.73 million.
The firm has a total of 7 workers. Let’s measure their productivity. In terms of profitability, gross margin is -166659512925868.62%, operating margin of -1.7475720455383152e+17%, and the pretax margin is -1.731788409314167e+17%.
PainReform Ltd (PRFX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of PainReform Ltd is 68.09%, while institutional ownership is 4.29%.
PainReform Ltd (PRFX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 2.88 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -8.4) by 11.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.92 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.92% per share during the next fiscal year.
PainReform Ltd (NASDAQ: PRFX) Trading Performance Indicators
Check out the current performance indicators for PainReform Ltd (PRFX). In the past quarter, the stock posted a quick ratio of 0.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.29, a number that is poised to hit -4.74 in the next quarter and is forecasted to reach -12.06 in one year’s time.
Technical Analysis of PainReform Ltd (PRFX)
Analysing the last 5-days average volume posted by the [PainReform Ltd, PRFX], we can find that recorded value of 1.23 million was better than the volume posted last year of 0.12 million. As of the previous 9 days, the stock’s Stochastic %D was 10.20%. Additionally, its Average True Range was 0.28.
During the past 100 days, PainReform Ltd’s (PRFX) raw stochastic average was set at 2.97%, which indicates a significant decrease from 13.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 208.62% in the past 14 days, which was higher than the 125.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0278, while its 200-day Moving Average is $7.7822. Now, the first resistance to watch is $1.0114. This is followed by the second major resistance level at $1.1156. The third major resistance level sits at $1.2013. If the price goes on to break the first support level at $0.8215, it is likely to go to the next support level at $0.7358. Now, if the price goes above the second support level, the third support stands at $0.6316.
PainReform Ltd (NASDAQ: PRFX) Key Stats
There are currently 2,026K shares outstanding in the company with a market cap of 1.06 million. Presently, the company’s annual sales total 0 K according to its annual income of -9,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,310 K.
